Skip to main content
Clinical Trials/NCT04180345
NCT04180345
Unknown
Not Applicable

Flare_IBD: Development and Validation of a Questionnaire Based on Patients' Messages on an Internet Forum for Early Detection of Flare in Inflammatory Bowel Disease

Central Hospital, Nancy, France0 sites260 target enrollmentJanuary 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammatory Bowel Diseases
Sponsor
Central Hospital, Nancy, France
Enrollment
260
Primary Endpoint
Scale calibration of the new developped questionnaire
Last Updated
6 years ago

Overview

Brief Summary

Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel disease (IBD) are chronic disabling conditions characterized by flares followed by periods of remission. However, IBD patients are seen every 3 to 6 months in the outpatient clinic, and the occurrence of a flare between two outpatient visits is not captured. In the current state of knowledge, there is no validated patient-reported outcome (PRO) tool to measure the phenomenon of flare in IBD. This study aimed to use an innovative methodology to collect messages posted by patients in an Internet forum for developing and validating a PRO measuring flare in IBD.

The design involves 1) Engineering sciences for scraping extraction of messages posted in an Internet forum and for Identification of messages related to flare, 2) Qualitative methods for thematic content analyze of the messages posted, for candidate items generation, for items selection (Delphi process) and for items adjustment ("think aloud" interviews), 3) Quantitative methods for psychometric validation of the PRO.

Registry
clinicaltrials.gov
Start Date
January 2020
End Date
February 2021
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Central Hospital, Nancy, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Every patient consulting the gastroenterology unit of Nancy University Hospital with a confirmed IBD diagnosis, regardless of the patient's state or treatment will be considered for inclusion

Exclusion Criteria

  • patients with a diagnosis \< 3 months.
  • Protected persons (minors, adults under guardianship, pregnant or breastfeeding women, people living in a public health or social institution, patients in an emergency situation, incarcerated individuals)

Outcomes

Primary Outcomes

Scale calibration of the new developped questionnaire

Time Frame: About 30 minutes

Weighing scale calibration

Construct validity of the new developped questionnaire

Time Frame: About 30 minutes

Exploratory factor analysis, discriminant validity by Kruskal-Wallis tests

Convergence proprieties of the new developped questionnaire

Time Frame: about 30 minutes

Convergence test of Flare-IBD scores with objective biological markers and clinical markers used in routine clinical practice

Reproductibility of the new developped questionnaire

Time Frame: Up to 8 days

Investigation of test-retest reliability with a second questionnaire administered 8 days later.

Similar Trials